| Cash Flow | 2025-07-31 |
|---|---|
| Net earnings | 3,159 |
| Depreciation and amortization | 1,549 |
| Provision for credit losses | 19 |
| Stock-based compensation expense | 521 |
| Deferred income taxes | -154 |
| Accrued payment in kind ('pik') interest | 445 |
| Amortization of deferred financing costs | 94 |
| Receivables | -5,468 |
| Inventories | 2,074 |
| Accounts payable and other accrued expenses | -1,525 |
| Deferred revenue | -1,090 |
| Other, net | -621 |
| Net cash provided by (used in) operating activities | 5,791 |
| Capital expenditures | 771 |
| Net cash used in investing activities | -771 |
| Repayments on term loan | 750 |
| Proceeds from short-term borrowings | 1,377 |
| Repayments on short-term borrowings | 1,869 |
| Payments on sale-leaseback financing transaction | 207 |
| Payments on long-term lease obligations | 14 |
| Net cash (used in) provided by financing activities | -1,463 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -280 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 3,277 |
KEWAUNEE SCIENTIFIC CORP DE (KEQU)
KEWAUNEE SCIENTIFIC CORP DE (KEQU)